In this webinar, we introduce how Backgrounded Membrane Imaging (BMI) can be used to analyze subvisible particles (SVP), an indicator of drug efficacy and safety. BMI is a fully automated form of USP <788> membrane microscopy available on the Horizon instrument that delivers 96-well automation and rapidly generates accurate particle counts and sizing data in a low volume, high throughput format. With BMI, SVP analysis can be incorporated at any stage of biologic development – from candidate selection to formulation screening, process development, and analytical – providing key insights that reduce drug development risk and time to market.